About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 739010, 8 pages
http://dx.doi.org/10.1155/2013/739010
Research Article

The Italian National External Quality Assessment Program in Molecular Genetic Testing: Results of the VII Round (2010-2011)

1National Centre of Rare Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy
2E. O. Ospedali Galliera, S.C. Laboratorio di Genetica, 16128 Genova, Italy
3Dipartimento di Scienze Biomediche e Biotecnologie, Università di Cagliari, 09121 Cagliari, Italy
4SOD Diagnostica, AOU Careggi, 50134 Firenze, Italy
5Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
6Department of Reproduction and Growth, Operative Unit of Medical Genetics, University Hospital S. Anna, Ferrara, Italy
7Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, 09121 Cagliari, Italy
8Dipartimento di Scienze Biomediche ed Oncologia Umana, University of Bari, 70124 Bari, Italy
9Laboratory of Molecular Genetics, Istituto Auxologico Italiano, Cusano Milanino, 20135 Milano, Italy
10Laboratorio di Genetica Medica, Fondazione IRCCS Policlinico Ca' Granda Ospedale, Milano, Italy
11Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, Istituto Nazionale per la Ricerca sul Cancro (IST), Genova, Italy

Received 26 October 2012; Revised 21 December 2012; Accepted 28 December 2012

Academic Editor: Ozgur Cogulu

Copyright © 2013 F. Censi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. C. Libeer, “Role of external quality assurance schemes in assessing and improving quality in medical laboratories,” Clinica Chimica Acta, vol. 309, no. 2, pp. 173–177, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. Conferenza Stato-Regioni 15 luglio 2004.
  3. OECD, Guidelines for Quality Assurance in Molecular Genetic Testing, OECD, Paris, France, 2007.
  4. R. J. Hastings and R. T. Howell, “The importance and value of EQA for diagnostic genetic laboratories,” Journal of Community Genetics, vol. 1, no. 1, pp. 11–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Berwouts, E. Girodon, M. Schwarz, et al., “Improvement of interpretation in cystic fibrosis clinical laboratory reports: longitudinal analysis of external quality assessment data,” European Journal of Human Genetics, vol. 20, no. 12, pp. 1209–1215, 2012. View at Publisher · View at Google Scholar
  6. Guidelines for Genetic Tests, 1999—Linee Guida per i test genetici, http://www.cnmr.iss.it/lgui, 1999.
  7. S. C. Ramsden, Z. Deans, D. O. Robinson et al., “Monitoring standards for molecular genetic testing in the United Kingdom, the Netherlands, and Ireland,” Genetic Testing, vol. 10, no. 3, pp. 147–156, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Sciacovelli, S. Secchiero, L. Zardo, M. Zaninotto, and M. Plebani, “External quality assessment: an effective tool for clinical governance in laboratory medicine,” Clinical Chemistry and Laboratory Medicine, vol. 44, no. 6, pp. 740–749, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Chen, M. Gagnon, S. Shahangian, et al., “Good laboratory practices for molecular genetic testing for heritable diseases and conditions,” MMWR Recommendations and Reports, vol. 58, no. RR-6, pp. 1–37, 2009.
  10. C. S. Richards and W. W. Grody, “Alternative approaches to proficiency testing in molecular genetics,” Clinical Chemistry, vol. 49, no. 5, pp. 717–718, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. K. E. Weck, B. Zehnbauer, M. Datto, et al., “Molecular genetic testing for fragile X syndrome: laboratory performance on the College of American Pathologists proficiency survey (2001–2009),” Gentics in Medicine, vol. 14, no. 3, pp. 306–312, 2012. View at Publisher · View at Google Scholar
  12. D. Taruscio, V. Falbo, G. Floridia et al., “Quality assessment in cytogenetic and molecular genetic testing: the experience of the Italian Project on Standardisation and Quality Assurance,” Clinical Chemistry and Laboratory Medicine, vol. 42, no. 8, pp. 915–921, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. Official Bulletin of the Italian Republic-G.U. n.199 del 28/08/2009.
  14. M. Salvatore, V. Falbo, G. Floridia et al., “The Italian External Quality Control Programme for cystic fibrosis molecular diagnosis: 4 years of activity,” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 2, pp. 254–260, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Falbo, G. Floridia, F. Tosto et al., “The Italian External Quality Assessment scheme for fragile X syndrome: the results of a 5-year survey,” Genetic Testing, vol. 12, no. 2, pp. 279–288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Tosto, M. Salvatore, V. Falbo et al., “The Italian scheme of External Quality Assessment for beta-thalassemia: genotyping and reporting results and testing strategies in a 5-year survey,” Genetic testing and molecular biomarkers, vol. 13, no. 1, pp. 31–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Censi, V. Falbo, G. Floridia et al., “The Italian external quality control program for familial adenomatous polyposis of the colon: five years of experience,” Genetic Testing and Molecular Biomarkers, vol. 14, no. 2, pp. 175–181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Castellani, H. Cuppens, M. Macek et al., “Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice,” Journal of Cystic Fibrosis, vol. 7, no. 3, pp. 179–196, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Dequeker, M. Stuhrmann, M. A. Morris et al., “Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders - Updated European recommendations,” European Journal of Human Genetics, vol. 17, no. 1, pp. 51–65, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Grasso, M. A. Melis, A. Murgia, et al., Proposta Linee guida per la diagnosi molecolare della Sindrome dell'X Fragile (Proposed Guideline for Fragile X Diagnosis), http://www.sigu.net/index.php?option=com_docman&task=cat_view&gid=46&limitstart=15, 2008.
  21. S. Berwouts, K. Fanning, M. A. Morris, et al., “Quality assurance practices in Europe: a survey of molecular genetic testing laboratories,” European Journal of Human Genetics, vol. 20, no. 11, pp. 1118–1126, 2012. View at Publisher · View at Google Scholar
  22. I. Touitou, C. Rittore, L. Philibert, J. Yagüe, Y. Shinar, and I. Aksentijevich, “An international external quality assessment for molecular diagnosis of hereditary recurrent fevers: a 3-year scheme demonstrates the need for improvement,” European Journal of Human Genetics, vol. 17, no. 7, pp. 890–896, 2009. View at Publisher · View at Google Scholar · View at Scopus